Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Sunho Pharmaceutical Co., Ltd. is a prominent pharmaceutical manufacturing and CDMO subsidiary of the Beijing Sunho Pharmaceutical group (Xinghao Pharmaceutical). Based in Zhongshan, China, the company operates high-end GMP-compliant facilities with EU GMP and US FDA certifications, specializing in complex injections, sustained-release preparations, and immediate-release oral thin films. As part of the broader SunHo ecosystem, which includes the Hong Kong-listed SunHo (China) Biopharmaceutical, the company supports the development and production of both generic drugs and innovative biologics. Its innovative pipeline is highlighted by first-in-class immunocytokines and bifunctional antibody fusion proteins targeting oncology and autoimmune diseases. Guangdong Sunho provides comprehensive CMC/CDMO services from early-stage clinical supply to large-scale commercial manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Sunho Pharmaceutical.